CAPVAXIVE
Analogs of CAPVAXIVE
Find cheaper analogs and generic equivalents for CAPVAXIVE.
सक्रिय अवयव: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE DEOAC15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 16F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 35B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 24F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F
उत्पाद अवलोकन
About CAPVAXIVE
CAPVAXIVE is a vaccine designed to protect against pneumococcal disease, a serious infection caused by the bacterium Streptococcus pneumoniae. This vaccine contains a combination of pneumococcal polysaccharide serotypes, including 17F, 9N, 20A, 33F, 23B, 10A, 31, 7F, 19A, DEOAC15B, 8, 16F, 12F, 6A, 23A, 3, 35B, 24F, 15A, 11A, and 22F.
Key Benefits & Uses
- Prevention of pneumococcal disease, including pneumonia, meningitis, and sepsis.
- Protection against invasive pneumococcal disease caused by the listed serotypes.
- Reduced risk of hospitalization and mortality due to pneumococcal disease.
Active Ingredient & Action
The active ingredients in CAPVAXIVE work by stimulating the body's immune system to produce antibodies that recognize and fight the pneumococcal bacteria. The vaccine contains a combination of pneumococcal polysaccharides, which are complex carbohydrates that are part of the bacterial cell wall. These polysaccharides are conjugated to a carrier protein, CRM-197, which helps to enhance the immune response. When administered, the vaccine stimulates the production of antibodies that can recognize and bind to the pneumococcal bacteria, helping to prevent infection.
Important Notes
CAPVAXIVE should be administered according to the recommended schedule and guidelines. It is essential to follow the instructions provided by the healthcare provider or the vaccine manufacturer. Individuals with a history of severe allergic reactions, weakened immune systems, or certain medical conditions should consult their healthcare provider before receiving the vaccine. As with any vaccine, CAPVAXIVE may cause side effects, such as pain, redness, or swelling at the injection site, fever, or fatigue. If you experience any unusual or severe side effects, seek medical attention immediately.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.